Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 10, 2016 4:18 PM ET


Company Overview of EPIRUS Biopharmaceuticals, Inc.

Executive Profile

Mark H. N. Corrigan M.D.

AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Mark H. N. Corrigan, M.D. served as the Chief Executive Officer and President of Zalicus Inc. from January 2010 to June 2014. Dr. Corrigan is a seasoned life sciences executive. Dr. Corrigan joined the specialty pharmaceutical company Sepracor Inc. in 2003. He served as an Executive Vice President of Research & Development of Sunovion Pharmaceuticals Inc. (formerly, Sepracor Inc.) from April 21, 2003 to December 2009. He has over 20 years of experience in treating ...

Corporate Headquarters

699 Boylston Street
Boston, Massachusetts 02116

United States

Phone: 617-600-4313
Fax: --

Board Members Memberships

Director and Chairman of Compensation Committee


University of Virginia
University of Virginia

Other Affiliations

Annual Compensation

Total Annual Compensation$278,833

Stocks Options

Restricted Stock Awards$367,500
All Other Compensation$1,060,129
Exercisable Options$156,654
Total Number of Options$156,654

Total Compensation

Total Annual Cash Compensation$1,368,962
Total Short Term Compensation$278,833
Other Long Term Compensation$1,427,629
Total Calculated Compensation$1,900,884

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact EPIRUS Biopharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at